Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.21.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Common Stock Subscribed But Not Issued [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Total
Balances at December 31, 2020 at Dec. 31, 2019 $ 228,408 $ 1,168,074 $ 112,245,730 $ (106,760,527) $ (553,465) $ 6,328,220
Shares outstanding, beginning balance at Dec. 31, 2019 228,408,024 3,236,857        
Issuance of subscribed shares $ 3,237 $ (1,168,074) 1,164,837
Shares, Outstanding, Beginning Balance 3,236,857 (3,236,857)        
Stock grants $ 5,365 5,365
Shares outstanding, beginning balance   30,307        
Shares, Outstanding, Beginning Balance          
Amortization of option grants 317,355 317,355
Discount on debentures payable 28,021 28,021
Beneficial conversion feature on debentures payable 379,183 379,183
Conversion of debentures payable $ 8,584 1,796,073 1,804,657
Shares, Outstanding, Beginning Balance 8,584,276          
Conversion of common stock to preferred stock $ (4,908) (14,720,092) (14,725,000)
Conversion of common stock to preferred stock, shares (4,908,333)          
Shares, Outstanding, Beginning Balance          
Shares, Outstanding, Beginning Balance          
Distributions (100,905) (100,905)
Net income (loss) (2,421,444) 83,728 (2,337,716)
Balances at March 31, 2021 at Mar. 31, 2020 $ 235,321 $ 5,365 101,211,107 (109,181,971) (570,642) (8,300,820)
Shares outstanding, beginning balance at Mar. 31, 2020 235,320,824 30,307        
Balances at December 31, 2020 at Dec. 31, 2019 $ 228,408 $ 1,168,074 112,245,730 (106,760,527) (553,465) 6,328,220
Shares outstanding, beginning balance at Dec. 31, 2019 228,408,024 3,236,857        
Balances at March 31, 2021 at Dec. 31, 2020 $ 314,419 $ 5,365 112,974,329 (104,616,538) (577,139) 8,100,436
Shares outstanding, beginning balance at Dec. 31, 2020 314,418,812 11,413        
Issuance of subscribed shares $ 11 $ (5,365) 5,354
Shares, Outstanding, Beginning Balance 11,413          
Stock grants $ 5,365 5,365
Shares outstanding, beginning balance   6,877        
Exercise of warrants $ 50 7,450 7,500
Shares, Outstanding, Beginning Balance 50,000          
Amortization of option grants 294,598 294,598
Issuance of stand-alone warrants 55,786 55,786
Conversion of debentures payable $ 4,611 1,351,841 1,356,452
Shares, Outstanding, Beginning Balance 4,610,645          
Conversion of promissory notes $ 3,366 1,006,426 1,009,792
Shares, Outstanding, Beginning Balance 3,365,972          
Common stock issued to settle obligations $ 43 31,243 31,286
Shares, Outstanding, Beginning Balance 42,857          
Equity issuance costs (386,983) (386,983)
Distributions (82,558) (82,558)
Net income (loss) 4,219,903 90,123 4,310,026
Balances at March 31, 2021 at Mar. 31, 2021 $ 322,500 $ 5,365 $ 115,340,044 $ (100,396,635) $ (569,574) $ 14,701,700
Shares outstanding, beginning balance at Mar. 31, 2021 322,499,699 6,877        
Shares outstanding, beginning balance   (11,413)